Electromed (ELMD) vs LivaNova (LIVN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
LivaNova (LIVN) has outperformed Electromed (ELMD) over the past year, gaining 46.6% versus a gain of 9.6%. Over five years, ELMD leads with a +152.0% price change compared with -9.5% for LIVN. LivaNova is the larger company by market cap ($4.20 billion vs $229.5 million), about 18.3 times the size.
On valuation, LivaNova trades at a lower forward P/E (16.3x vs 45.4x for Electromed).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELMD | LIVN |
|---|---|---|
| Share price | $27.69 | $76.39 |
| Market cap | $229.47M | $4.20B |
| 1-day change | -0.40% | +0.63% |
| YTD return | -4.91% | +24.15% |
| 1-year return | +9.58% | +46.59% |
| 5-year return | +151.96% | -9.51% |
| P/E ratio (TTM) | 21.47 | 22.47 |
| Forward P/E | 45.39 | 16.31 |
| EPS (TTM) | $1.29 | $3.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.39B |
| Revenue growth (YoY) | — | +10.74% |
| Net income (latest FY) | — | $-242.47M |
| Gross margin | — | 67.71% |
| Operating margin | — | 14.36% |
| Net margin | — | -17.47% |
| 52-week high | $47.40 | $85.76 |
| 52-week low | $23.01 | $48.82 |
| Distance from 52-week high | -41.58% | -10.93% |
| Analyst consensus | none | buy |
| Avg. price target upside | +75.15% | +18.54% |
| Average volume | 97.22K | 648.38K |
| Shares outstanding | 8.29M | 54.93M |
| Employees | 195 | 3,300 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LivaNova is about 18.3 times larger than Electromed by market value ($4.20B vs $229.47M).
- LIVN has outperformed ELMD by 37.0 percentage points over the past year.
About Electromed
ELMD stock →Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees
About LivaNova
LIVN stock →LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,300 employees
ELMD vs LIVN FAQ
Which is bigger, Electromed or LivaNova?
LivaNova (LIVN) is larger, with a market capitalization of $4.20B compared with $229.47M for Electromed (ELMD).
Which stock has performed better over the past year, ELMD or LIVN?
LIVN returned +46.59% over the past 12 months, compared with +9.58% for ELMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ELMD or LIVN?
ELMD has the lower trailing P/E at 21.5, versus 22.5 for LIVN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Electromed and LivaNova in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.